Introduction
Cancer chemotherapy can be used depending on the cancer status either alone or in combination with surgery and/or radiotherapy. The effectiveness of chemotherapy in treatment of cancer patients is largely due to the cytostatic and cytotoxic effects of the drugs on tumor cells. Additionally, the cell cycle status of tumor cells is important in determining the effectiveness of chemotherapy because these agents are mainly active against proliferating S-or Mphase cells rather than resting (G 0 ) cells [1] . However, many chemotherapeutic drugs cannot distinguish proliferating normal cells from tumor cells, thereby causing damage to normal cells, which leads to side-effects.
Several biochemical mechanisms have been implicated in chemotherapy-mediated tumor cell death, including apoptosis, necrosis, and autophagy [2] [3] [4] . However, the mechanism of this cell death requires further studies in order to elucidate whether the cytotoxic effect is confined to tumor rather than normal cells. Chemotherapy-induced apoptotic cell death in tumor cells causes the formation of apoptotic bodies that surrounding cells can remove without provoking a local inflammatory response. In contrast, tumor cell necrosis results in the release of intracellular contents, thereby provoking a damaging inflammatory response [5, 6] . Thus, apoptosis induction is regarded as an efficient process by which malignant tumor cells can be removed following chemotherapeutic treatments [7] [8] [9] .
Three different death signaling pathways are involved in the chemotherapeutic drug-induced apoptosis of tumor cells. These include the intrinsic mitochondria-mediated apoptotic pathway [10] , the intrinsic endoplasmic reticulum stress-mediated apoptotic pathway [11] , and the extrinsic death receptor-mediated apoptotic pathway [12] . Tumor cell apoptosis that is provoked by DNA-and microtubuledamaging chemotherapeutic drugs has been reported to be mainly exerted by the intrinsic mitochondria-mediated apoptotic pathway [1] .
Autophagy is an intracellular destructive mechanism and proceeds by sequestering dysfunctional or unnecessary intracellular components via the formation of doublemembrane autophagosomes. The sequestered components are subsequently degraded via the fusion between autophagosomes and lysosomes to generate single-membrane autolysosomes. It has been shown that the autophagic capacity is elevated in tumor cells compared with their normal counterparts [13] . This provides tumor cells with a survival advantage under stress conditions such as chemotherapeutic treatment as well as nutritional deprivation. Because tumor cells can induce autophagy following exposure to chemotherapy, the pharmacologic inhibition of autophagy may be a promising approach to promote tumor cell death [14] . Numerous chemotherapeutic agents have been reported to induce the autophagic response in tumor cells [15] . However, it remains uncertain whether autophagy activation, which occurs following chemotherapeutic drug treatment, contributes to tumor cell death or represents a cellular survival mechanism to protect from the drugmediated cell death.
Previously, we sought to isolate a pharmacologically safe apoptogenic substance from various edible plants, based on the simple concept that edible plant-derived components that are cytotoxic to tumors may be less toxic to normal cells. The purification of an antitumor ingredient from barnyard millet (Echinochloa esculenta (A. Braun)) grains, by serial solvent extractions and silica gel column chromatography, led to identification of the flavonoid derivative acacetin (5,7-dihydroxy-4'-methoxyflavone), which induced apoptosis in several human cancer cell lines including cervical, liver, gastric, prostate, breast, and T cell leukemia cells [16] [17] [18] [19] [20] [21] . However, the relationship between the acacetin-induced apoptotic signaling pathway and cellular autophagy activity requires further investigation to evaluate the efficacy of acacetin as an antitumor agent. Thus, in the present study, we examined whether acacetin-induced autophagy protected human acute leukemia Jurkat T cells from apoptosis or promoted apoptosis. We also assessed how acacetinmediated Bak activation contributed to the crosstalk between apoptosis and autophagy in Jurkat T cells.
Materials and Methods
Reagents, Antibodies, and Cells Acacetin (5,7-dihydroxy-4'-methoxyflavone), 3,3'dihexyloxacarbocyanine iodide (DiOC 
Flow Cytometric and Fluorescence Microscopic Analyses
Flow cytometric analyses of apoptotic alterations in the cell cycle status of acacetin-treated cells were performed as described previously [9] . Both apoptotic and necrotic cells were detected using a FITC-Annexin V apoptosis kit as described previously [9] . The mitochondrial membrane potential (Δψm) loss provoked after acacetin treatment was measured after DiOC 6 staining [22] . Acacetin-induced activation of Bak and Bax was measured as described previously [23] .
For measurements of the intracellular formation of acidic vesicular organelles (AVOs) or autophagolysosome vacuoles, well-known features of autophagy, cells exposed to acacetin were incubated with phenol red-free RPMI 1640 medium containing 2 μg/ml acridine orange at 37°C for 30 min in a humidified 5% CO 2 incubator [24] . Acridine orange-positive cells were detected by flow cytometry and fluorescence microscopy.
Cytotoxicity Assay
Cytotoxicity of acacetin was assessed by the MTT assay. Briefly, cells (5 × 10 4 ) were added to a serial dilution of acacetin in 96-well plates. Following incubation for 20 h, MTT solution (50 μl, 1.1 mg/ml) was added to each well and incubated further for 4 h. After centrifugation, the supernatant was removed from each well, and dimethyl sulfoxide (150 μl) was added to dissolve the colored formazan crystals. The resulting absorbance values were measured at 540 nm by a plate reader.
Cell Lysates and Western Blot Analyses
To prepare cell lysates, cells (5 × 10 6 cells) were solubilized in 200 μl of lysis buffer as described elsewhere [9] . Protein lysates (25 μg) were subjected to electrophoresis on 4-12% NuPAGE gradient gels and then electrotransferred to a nylon membrane. Protein detection was carried out using an ECL western blot kit as described previously [9] . Densitometry was carried out using ImageQuant TL software (Amersham). Arbitrary densitometric units of each protein of interest were normalized to the densitometric units of β-actin.
Statistical Analyses
All discrete values, expressed as the mean ± SD, were analyzed using Student's t-test. P-values less than 0.05 were considered as significant.
Results and Discussion
Apoptotic Activity of Acacetin toward J/Neo and J/Bcl-xL Cells
The cytotoxicity of increasing concentrations of acacetin is shown in Fig. 1B . To determine whether the Bcl-xLsensitive apoptotic cell death is a key mediator of acacetininduced cytotoxicity, we compared the acacetin-induced cytotoxicity, sub-G 1 accumulation, and FITC-Annexin Vstainable phosphatidylserine externalization at the cytoplasmic membrane of J/Neo and J/Bcl-xL cells. As determined by MTT assay, the viability of J/Neo cells treated with 5.0, 7.5, and 10 μg/ml acacetin for 20 h was reduced to the level of 93.9%, 73.8%, and 55.0%, respectively. Under the same time condition, acacetin-induced cytotoxicity was completely abrogated in J/Bcl-xL cells, indicating that the cytotoxicity of acacetin was attributable to Bcl-xL-sensitive apoptotic cell death (Fig. 1B) . When the acacetin-induced sub-G 1 peak representing apoptotic cells was compared in J/Neo and J/ Bc-xL cells, the sub-G 1 cell ratio of J/Neo cells treated with acacetin (5.0, 7.5, and 10 μg/ml) was 16.6%, 31.3%, and 47.4% of the total cells, respectively. In contrast, the apoptotic sub-G 1 cells were barely detected in J/Bcl-xL cells (Fig. 1C) .
To examine whether acacetin-induced enhancement of the sub-G 1 rate in J/Neo cells was due to apoptosis or apoptosis accompanying necrosis, the cells were analyzed by flow cytometry using FITC-Annexin V and propidium iodide (PI) staining. Although treatment of J/Neo cells with 10.0 μg/ml acacetin for 20 h caused a barely detectable increase in the level of necrotic cells stained only with PI, the early apoptotic cells stained only with FITC-Annexin V, and late apoptotic cells stained with both FITC-Annexin V and PI, increased to 26.2% and 15.3%, respectively (Fig. 1D) . Apoptosis is known to undergo a series of morphological changes such as cellular shrinkage and phosphatidylserine exposure on the external surface of the cytoplasmic membrane, whereas necrosis exhibits cellular swelling and dilation of organelles, resulting in the plasma membrane ruptures [25] . In this context, we compared the forward scatter distributions of unstained cells, early apoptotic cells (FITC-Annexin V-positive and PI-negative), and late apoptotic cells (FITC-Annexin V-and PI-positive) between J/Neo and J/Bcl-xL cells following exposure to 10 μg/ml acacetin for 20 h. Whereas the light scattering characteristics of the unstained live cells were not changed by acacetin, both late and early apoptotic J/Neo cells commonly showed a reduction in forward scatter. This indicates that acacetin-induced apoptotic cell death was not accompanied by cellular swelling but by a reduction in cell size. Additionally, acacetin failed to induce an increase in the early and late apoptotic cells in J/Bcl-xL cells.
These results demonstrate that treatment of Jurkat T cells with acacetin (5.0-10 μg/ml) provoked apoptotic cell death dosage-dependently. These results also suggest that the cytotoxic effect of acacetin on Jurkat T cells was mainly attributable to apoptosis mediated by the Bcl-xL-sensitive apoptotic pathway, but not to necrosis.
Induction of Bak Activation and Mitochondria-Dependent Caspase Cascade Activation during Acacetin-Induced Apoptosis
The loss of Δψm, mitochondrial cytochrome c release into the cytoplasm, and the caspase cascade activation are hallmark events of apoptosis [26] . To examine the involvement of mitochondrial damage in acacetin-induced apoptosis, the Δψm loss of J/Neo and J/Bcl-xL cells was analyzed by flow cytometry using DiOC /well) were incubated with acacetin at indicated doses in a 96-well plate for 20 h and further incubated with MTT for 4 h to measure cell viability. Data are expressed as the mean ± SD (n = 3 with three replicates per independent experiment). *p < 0.05 compared with control. Cell cycle distribution and Annexin V-positive apoptotic cells were analyzed by flow cytometry after staining of cells by PI and FITC-Annexin V/PI, respectively. The lower left, lower right, upper right, and upper left quadrants represent unstained live, early apoptotic, late apoptotic, and necrotic cells, respectively. The forward scatter properties of unstained live, early apoptotic, and late apoptotic cells detected after treatment with 10 μg/ml acacetin were assessed to determine alterations in cell size during apoptosis. A representative study is presented and two additional experiments yielded similar results.
with acacetin at concentrations of 5.0, 7.5, and 10 μg/ml were 12.1%, 29.5%, and 42.3%, respectively ( Fig. 2A) . However, the acacetin-induced Δψm loss was completely blocked in J/Bcl-xL cells.
In relation to regulation of the intrinsic mitochondriadependent pathway of apoptosis, multidomain pro-apoptotic Bcl-2 family proteins such as Bak and Bax are known to mediate permeabilization of the mitochondrial outer membrane; however, anti-apoptotic Bcl-2 family proteins such as Bcl-2, Bcl-xL, and Mcl-1 suppress the Bak-or Baxmediated cytochrome c efflux, either directly or by inactivating BH3-only pro-apoptotic Bcl-2 family proteins, including Bad, Bid, and Bim [27, 28] . To compare the involvement of Bak and Bax activation in the acacetininduced apoptotic pathway in J/Neo and J/Bcl-xL, flow cytometric anayses using conformation-specific anti-Bak (Ab-1) or anti-Bax (6A7) antibodies were carried out. As shown in Fig. 2B , Bak activation was observed in J/Neo, but not in J/Bcl-xL cells. In contrast, Bax activation was not observed in J/Neo and J/Bcl-xL cells (data not shown). These results demonstrate that Bak activation, but not Bax activation, was involved in the acacetin-induced Δψm loss.
We next decided to examine the upstream pro-apoptotic events that contribute to acacetin-induced Bak activation. Because the enhancement of the expression ratio of proapoptotic Bcl-2 family proteins to anti-apoptotic Bcl-2 family proteins has been associated with the activation of Bak and/or Bax [26, 27] , the expression levels of the proapoptotic Bak, Bid, and Bim and the anti-apoptotic Bcl-xL, Bcl-2, and Mcl-1 were compared by western blot analyses between J/Neo and J/Bcl-xL cells treated with acacetin. As shown in Fig. 2C , the levels of Bcl-xL, Bcl-2, and Mcl-1 were slightly reduced in J/Neo cells following acacetin treatment. However, neither the electrophoretic mobility reduction of Bim during SDS-polyacrylamide gel electrophoresis, indicating its activation [22] , nor an elevation of Bak level was detected. Because several studies reported that Bak activation and resultant Δψm loss precede the release of mitochondrial cytochrome c into the cytosol, leading to activation of caspase-9 and caspase-3 [29] [30] [31] , it was likely that Δψm loss causing cytochrome c release and the caspase cascade activation, which could be targeted by the antiapoptotic function of Bcl-xL, were crucial for acacetininduced apoptosis of Jurkat T cells. To confirm this possibility, we used western blot analyses to determine whether acacetin-induced apoptosis was accompanied by caspase cascade activation in J/Neo and J/Bcl-xL cells. In agreement with the Δψm loss, caspase-9 activation via proteolytic cleavage of inactive procaspase-9 (47 kDa) to its active forms (37/35 kDa) was observed in J/Neo cells (Fig. 2C) . In addition, caspase-3 activation, based on the cleavage of the 32 kDa proenzyme into its 17 kDa active enzyme, and degradation of PARP were detected in J/Neo cells. In contrast, all of these apoptotic responses were abrogated in J/Bcl-xL cells.
These results demonstrate that acacetin induced apoptosis via Bak activation, Δψm loss, activation of caspase-9 and caspase-3, and degradation of PARP, all of which could be prevented by overexpressing Bcl-xL.
Simultaneous Induction of Cytoprotective Autophagy and Apoptosis in Acacetin-Treated Jurkat T Cells
A previous report indicated that the autophagic capacity was promoted in tumor cells compared with their normal counterparts, rendering tumor cells resistant to chemotherapy [13] . To determine whether autophagy was elicited along with acacetin-induced apoptosis, we investigated the formation of AVOs or autophagolysosome vacuoles, the key features of autophagy, which occur as a consequence of fusion between autophagosomes and lysosomes [32] . Flow cytometric analyses showed that, whereas acridine orangestained AVOs were barely detected in untreated J/Neo cells, the formation of AVOs in J/Neo cells was enhanced following acacetin treatment. Acridine orange-positive cells in J/Neo cells treated with 5.0, 7.5, and 10 μg/ml acacetin accounted for 10.9%, 17.6%, and 23.9% of total cells, respectively (Fig. 3A) . Acacetin-induced formation of AVOs was unremarkable in J/Bcl-xL cells. Fluorescence microscopy also showed a significant enhancement in the acacetin-induced formation of AVOs in J/Neo and, to a much lesser extent, in J/Bcl-xL cells (Fig. 3B) .
Western blot analyses were performed to examine acacetin-induced cellular autophagic responses, including the Akt-mTOR pathway, and alterations of autophagic markers such as microtubule-associated protein 1 light chain 3-I (LC3-I, 16 kDa) conversion to LC3-II (14 kDa), down-regulation of polyubiquitin-binding protein p62/ sequestosome 1 (p62/SQSTM1), and phosphorylation of Beclin-1 (Ser-15). As the results, treatment of J/Neo cells with acacetin caused LC3-I/LC3-II conversion and Beclin-1 phosphorylation; however, these autophagic events were abrogated or barely induced in J/Bcl-xL cells (Fig. 3C) . At the same time, suppression of the Akt-mTOR pathway, as evidenced by a reduction in the levels of p-Akt (ser-472/473), p-mTOR (Ser-2448), p-p70 S6K (Thr-389), and p-Ulk1 (Ser-757), as well as down-regulation of p62/SQSTM1, were detected irrespective of Bcl-xL overexpression. These results demonstrate that acacetin-induced apoptosis is accompanied by autophagy, and suggest that overexpression of the antiapoptotic Bcl-xL protein, which blocks the activation of Bak and thus cytochorome c release from mitochondria into the cytosol [33, 34] , might also interfere with the acacetininduced autophagic pathway in Jurkat T cells via attenuating LC3-I/LC3-II conversion and Beclin-1 phosphorylation.
The impact of the autophagy inhibitors 3-MA and LY294002 on the acacetin-induced sub-G 1 accumulation and Δψm loss was determined to assess the contribution of autophagy to acacetin-induced apoptosis in J/Neo cells. When the cells were exposed to 7.5 μg/ml acacetin for 20 h, the acacetin-induced sub-G 1 accumulation and Δψm loss reached 30.7% and 23.3%, respectively (Figs. 4A and 4B). Under these conditions, these apoptotic sub-G 1 accumulation and Δψm loss were significantly enhanced by concomitant treatment with 500 μM 3-MA or 15 μM LY294002. Additionally, the acacetin-induced Bak activation was significantly enhanced by 3-MA or LY294002 (Fig. 4C) . Western blot analyses showed that acacetin-induced apoptotic responses, including activation of caspase-9 and caspase-3, and PARP degradation, were elevated by 3-MA or LY294002 (Fig. 4D) . It is noteworthy that although the acacetin-induced Bak activation and resultant mitochondrial damage-mediated caspase activation were elevated by 3-MA or LY294002, there was no remarkable increase in the level of Bak protein. The molecular mechanism responsible for the 3-MA-or LY294002-mediated enhancement of the acacetininduced Bak activation remains obscure. Consequently, current results indicate that the autophagic response provoked in J/Neo cells following acacetin treatment was to protect cells from mitochondrial damage via attenuating the acacetin-induced activation of Bak.
In conclusion, these results indicate that acacetin exerts its cytotoxic effect on Jurkat T cells by inducing apoptosis that proceeds via Bak activation, Δψm loss, mitochondriadependent activation of caspase-9 and caspase-3, and degradation of PARP. These apoptogenic effects of acacetin can be blocked by overexpressing the anti-apoptotic Bcl-xL protein. Simultaneously, acacetin induces cytoprotective autophagy, resulting from inhibition of the Akt-mTOR pathway. Importantly, addition of the autophagy inhibitors 3-MA or LY294002 augments Bak activation and subsequent promotion of mitochondria damage-dependent apoptosis.
These findings suggest that combining acacetin with an autophagy inhibitor may be a promising antitumor treatment.
